JOSE HAWAYEK CARRERA: Open Payments
NPI 1275080574 · OAKLAND PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,188 in 134 payments from 20 companies in 2025. Trend: 2023 $735 · 2024 $789 · 2025 $3,188
Food & beverage: $3,188
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 21 | $589 |
| Alkermes, Inc. | 16 | $390 |
| Teva Pharmaceuticals USA, Inc. | 16 | $330 |
| ABBVIE INC. | 17 | $325 |
| Otsuka America Pharmaceutical, Inc. | 11 | $283 |
| Janssen Pharmaceuticals, Inc | 12 | $261 |
| Vanda Pharmaceuticals Inc. | 6 | $174 |
| Axsome Therapeutics, Inc. | 3 | $156 |
| Lundbeck LLC | 6 | $124 |
| Braeburn Inc. | 5 | $105 |
Products named: INGREZZA, VRAYLAR, UZEDY, REXULTI, ARISTADA, Auvelity, INVEGA SUSTENNA, LYBALVI.
Industry payments across FL — which companies pay providers there.
